238 related articles for article (PubMed ID: 30999004)
1. Lipoxygenase drives lipidomic and metabolic reprogramming in ischemic heart failure.
Halade GV; Kain V; Tourki B; Jadapalli JK
Metabolism; 2019 Jul; 96():22-32. PubMed ID: 30999004
[TBL] [Abstract][Full Text] [Related]
2. Activation of EP4 receptor limits transition of acute to chronic heart failure in lipoxygenase deficient mice.
Kain V; Ingle KA; Rajasekaran NS; Halade GV
Theranostics; 2021; 11(6):2742-2754. PubMed ID: 33456570
[No Abstract] [Full Text] [Related]
3. Molecular and Cellular Differences in Cardiac Repair of Male and Female Mice.
Pullen AB; Kain V; Serhan CN; Halade GV
J Am Heart Assoc; 2020 Apr; 9(8):e015672. PubMed ID: 32295449
[TBL] [Abstract][Full Text] [Related]
4. Interaction of 12/15-lipoxygenase with fatty acids alters the leukocyte kinetics leading to improved postmyocardial infarction healing.
Halade GV; Kain V; Ingle KA; Prabhu SD
Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H89-H102. PubMed ID: 28411230
[TBL] [Abstract][Full Text] [Related]
5. Macrophage Specific Lipoxygenase Deletion Amplify Cardiac Repair Activating Tregs in Chronic Heart Failure.
Kain V; Grilo GA; Upadhyay G; Nadler JL; Serhan CN; Halade GV
J Leukoc Biol; 2024 May; ():. PubMed ID: 38785336
[TBL] [Abstract][Full Text] [Related]
6. Splenic leukocytes define the resolution of inflammation in heart failure.
Halade GV; Norris PC; Kain V; Serhan CN; Ingle KA
Sci Signal; 2018 Mar; 11(520):. PubMed ID: 29511119
[TBL] [Abstract][Full Text] [Related]
7. Arachidonate 5-lipoxygenase is essential for biosynthesis of specialized pro-resolving mediators and cardiac repair in heart failure.
Halade GV; Kain V; Hossain S; Parcha V; Limdi NA; Arora P
Am J Physiol Heart Circ Physiol; 2022 Oct; 323(4):H721-H737. PubMed ID: 36018758
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of FPR2 impaired leukocytes recruitment and elicited non-resolving inflammation in acute heart failure.
Kain V; Jadapalli JK; Tourki B; Halade GV
Pharmacol Res; 2019 Aug; 146():104295. PubMed ID: 31216426
[TBL] [Abstract][Full Text] [Related]
9. Temporal lipid profiling in the progression from acute to chronic heart failure in mice and ischemic human hearts.
Gowda SGB; Gowda D; Hou F; Chiba H; Parcha V; Arora P; Halade GV; Hui SP
Atherosclerosis; 2022 Dec; 363():30-41. PubMed ID: 36455306
[TBL] [Abstract][Full Text] [Related]
10. Interaction of aging with lipoxygenase deficiency initiates hypersplenism, cardiac dysfunction, and profound leukocyte directed non-resolving inflammation.
Kain V; Mat Y; Halade GV
Geroscience; 2022 Jun; 44(3):1689-1702. PubMed ID: 34932185
[TBL] [Abstract][Full Text] [Related]
11. Genetic deletion of 12/15 lipoxygenase promotes effective resolution of inflammation following myocardial infarction.
Kain V; Ingle KA; Kabarowski J; Barnes S; Limdi NA; Prabhu SD; Halade GV
J Mol Cell Cardiol; 2018 May; 118():70-80. PubMed ID: 29526491
[TBL] [Abstract][Full Text] [Related]
12. Lipoxygenase inhibitor ML351 dysregulated an innate inflammatory response leading to impaired cardiac repair in acute heart failure.
Tourki B; Black LM; Kain V; Halade GV
Biomed Pharmacother; 2021 Jul; 139():111574. PubMed ID: 33862495
[TBL] [Abstract][Full Text] [Related]
13. Defective branched chain amino acid catabolism contributes to cardiac dysfunction and remodeling following myocardial infarction.
Wang W; Zhang F; Xia Y; Zhao S; Yan W; Wang H; Lee Y; Li C; Zhang L; Lian K; Gao E; Cheng H; Tao L
Am J Physiol Heart Circ Physiol; 2016 Nov; 311(5):H1160-H1169. PubMed ID: 27542406
[TBL] [Abstract][Full Text] [Related]
14. Heart specific PGC-1α deletion identifies metabolome of cardiac restricted metabolic heart failure.
Kärkkäinen O; Tuomainen T; Mutikainen M; Lehtonen M; Ruas JL; Hanhineva K; Tavi P
Cardiovasc Res; 2019 Jan; 115(1):107-118. PubMed ID: 29931052
[TBL] [Abstract][Full Text] [Related]
15. Subacute treatment of carprofen facilitate splenocardiac resolution deficit in cardiac injury.
Halade GV; Kain V; Wright GM; Jadapalli JK
J Leukoc Biol; 2018 Dec; 104(6):1173-1186. PubMed ID: 30145840
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive targeted and non-targeted lipidomics analyses in failing and non-failing heart.
Halade GV; Dorbane A; Ingle KA; Kain V; Schmitter JM; Rhourri-Frih B
Anal Bioanal Chem; 2018 Mar; 410(7):1965-1976. PubMed ID: 29411084
[TBL] [Abstract][Full Text] [Related]
17. Ablation of cardiac TIGAR preserves myocardial energetics and cardiac function in the pressure overload heart failure model.
Okawa Y; Hoshino A; Ariyoshi M; Kaimoto S; Tateishi S; Ono K; Uchihashi M; Iwai-Kanai E; Matoba S
Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1366-H1377. PubMed ID: 30901275
[TBL] [Abstract][Full Text] [Related]
18. Direct Evidence that Myocardial Insulin Resistance following Myocardial Ischemia Contributes to Post-Ischemic Heart Failure.
Fu F; Zhao K; Li J; Xu J; Zhang Y; Liu C; Yang W; Gao C; Li J; Zhang H; Li Y; Cui Q; Wang H; Tao L; Wang J; Quon MJ; Gao F
Sci Rep; 2015 Dec; 5():17927. PubMed ID: 26659007
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive plasma metabolomic and lipidomic analyses reveal potential biomarkers for heart failure.
Zhou J; Chen X; Chen W; Zhong L; Cui M
Mol Cell Biochem; 2021 Sep; 476(9):3449-3460. PubMed ID: 33974232
[TBL] [Abstract][Full Text] [Related]
20. Metabolic transformation of fat in obesity determines the inflammation resolving capacity of splenocardiac and cardiorenal networks in heart failure.
Halade GV; Kain V; De La Rosa X; Lindsey ML
Am J Physiol Heart Circ Physiol; 2022 Jun; 322(6):H953-H970. PubMed ID: 35333119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
